Eli Lilly Drug Slows Alzheimer's in Major Trial

Eli Lilly Drug Slows Alzheimer's in Major TrialПодробнее

Eli Lilly Alzheimer's Drug Fails Major Test TrialПодробнее

Lilly drug slows Alzheimer's progression by 35% in trialПодробнее

Lilly: Experimental Alzheimer's drug slows cognitive declines in large trialПодробнее

Eli Lilly drug slows Alzheimer’s disease progression: Study | Elizabeth Vargas ReportsПодробнее

Eli Lilly drug slows Alzheimer’s disease progression: Study | NewsNation NowПодробнее

Eli Lilly Alzheimers drug slows cognitive declineПодробнее

Eli Lilly CEO: Alzheimer's drug trial shows slowed disease progression by 40-60% in early patientsПодробнее

Eli Lilly: Drug slows decline of Alzheimer'sПодробнее

Eli Lilly study shows Alzheimer's drug slows diseaseПодробнее

Another Alzheimer's drug one step closer to FDA approvalПодробнее

‘Remarkable’ drug reduces Alzheimer’s decline, study showsПодробнее

Drug found to slow Alzheimer’s by up to 60 percent in trialПодробнее

Eli Lilly says experimental drug slows Alzheimer's worseningПодробнее

A new experimental drug shows promise in fight against Alzheimer'sПодробнее

Eli Lilly CEO David Ricks on positive Alzheimer's drug trial dataПодробнее

FDA approves Lilly Alzheimer's drugПодробнее

Eli Lilly's Alzheimer's drug slows cognitive decline: StudyПодробнее

Promising trial for Alzheimer's treatmentПодробнее

Alzheimer's treatment: New drug slows cognitive decline by 35%, studies show • FRANCE 24 EnglishПодробнее